Company page

Cellyan Biotechnology Co., Ltd

Cellyan Biotechnology Co., Ltd, trading under the ticker HKPD, operates in the American market with a market capitalization of approximately $4.57 million. The company focuses on biotechnology solutions, aiming to advance health and wellness through innovative products. Cellyan is committed to research and development in the biotech sector to meet emerging healthcare needs.

profileHKPD:NASDAQAI content: aiUpdated June 24, 2026/company/hong-kong-pharma-digital-technology-holdings-limited-ordinary-shares/c-wtee243e
Cellyan Biotechnology Co., Ltd logo
Ticker
HKPD:NASDAQ
Asset type
Stock
Market cap
$4.6M
Sector
Transportation
Industry
Air Freight/Couriers
Exchange
NASDAQ
Currency
USD